Cargando…
MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway
Increasing evidence has demonstrated that microRNAs (miRNAs or miRs) play a variety of roles in tumor development, progression and chemosensitivity in a wide range of tumors. In this study, we found that miR-125a-5p exhibited a low expression in esophageal squamous cell carcinoma (ESCC) tissues and...
Autores principales: | Zhao, Yan, Ma, Ke, Yang, Shujun, Zhang, Xiaosan, Wang, Feng, Zhang, Xiaqing, Liu, Hongtao, Fan, Qingxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017156/ https://www.ncbi.nlm.nih.gov/pubmed/29767234 http://dx.doi.org/10.3892/ijo.2018.4409 |
Ejemplares similares
-
MicroRNA-125b exerts antitumor functions in cutaneous squamous cell carcinoma by targeting the STAT3 pathway
por: Tian, Ke, et al.
Publicado: (2020) -
LncRNA ZEB1‐AS1 down‐regulation suppresses the proliferation and invasion by inhibiting ZEB1 expression in oesophageal squamous cell carcinoma
por: Zhao, Yan, et al.
Publicado: (2019) -
MicroRNA-125b inhibits cell proliferation and induces cell apoptosis in esophageal squamous cell carcinoma by targeting BMF
por: Fan, Yan-Xin, et al.
Publicado: (2018) -
Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway
por: Fan, Tianli, et al.
Publicado: (2016) -
Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trial
por: Lu, Zhihao, et al.
Publicado: (2022)